Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session Transcript
Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)
Now we start the conference. Mr. Okubo, please go ahead.
Thank you. Thank you very much for your participating in the conference call today. Before starting, I would like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of today's presentation.
Now let me introduce today's presenters and the panel. Mr. Costa Saroukos, Chief Financial Officer; and Dr. Andrew Plump, President of R&D. First, we would like to start with some opening remarks from Costa. And after that, we will have a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
